RAPT Therapeutics, Inc.
RAPT
$32.00
-$0.34-1.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.34M | 7.20M | 7.22M | 8.01M | 6.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.37M | 19.54M | 19.27M | 54.47M | 19.79M |
| Operating Income | -19.37M | -19.54M | -19.27M | -54.47M | -19.79M |
| Income Before Tax | -17.58M | -17.64M | -17.17M | -53.25M | -18.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.58M | -17.64M | -17.17M | -53.25M | -18.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.58M | -17.64M | -17.17M | -53.25M | -18.43M |
| EBIT | -19.37M | -19.54M | -19.27M | -54.47M | -19.79M |
| EBITDA | -19.17M | -19.31M | -19.01M | -54.18M | -19.49M |
| EPS Basic | -0.65 | -0.65 | -0.64 | -9.12 | -3.79 |
| Normalized Basic EPS | -0.41 | -0.41 | -0.41 | -5.76 | -2.37 |
| EPS Diluted | -0.65 | -0.65 | -0.64 | -9.12 | -3.79 |
| Normalized Diluted EPS | -0.41 | -0.41 | -0.41 | -5.76 | -2.37 |
| Average Basic Shares Outstanding | 26.96M | 26.95M | 26.93M | 5.84M | 4.86M |
| Average Diluted Shares Outstanding | 26.96M | 26.95M | 26.93M | 5.84M | 4.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |